ATXI
Avenue Therapeutics, Inc. Common Stock
ATXI
ATXI
Delisted
ATXI was delisted on the 18th of March, 2025.
15 hedge funds and large institutions have $52.4K invested in Avenue Therapeutics, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 4 closing their positions.
Holders
15
Holders Change
+1
Holders Change %
+7.14%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
3
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Citadel Advisors
Miami,
Florida
|
$14.4K |
2 |
2
Millennium Management
New York
|
$4.65K |
3 |
HF
3
HRT Financial
New York
|
$4K |
4 |
TSS
4
Two Sigma Securities
New York
|
$4.43K |
5 |
CSS
5
Cubist Systematic Strategies
Stamford,
Connecticut
|
$1.76K |
Top Sellers
1 |
1
Bank of New York Mellon
New York
|
$0 |
2 |
SAM
2
Shikiar Asset Management
New York
|
$0 |
3 |
3
Osaic Holdings
Scottsdale,
Arizona
|
$0 |
4 |
4
Morgan Stanley
New York
|
$0 |
5 |
5
BlackRock
New York
|
$202 |